C2 - Technical Assistance Facility


This component enables short-term transfer of knowledge, practices and experience to support partner countries and (regional) organisations in improving different aspects of their drug policies and response in a holistic manner both regarding drug-supply and drug-demand reduction aspects as well as relevant cross-cutting issues, corresponding to their national and/or institutional priorities and needs.

By its nature, the TAF is expected to produce cumulative impacts and touch upon a wide range of constituents, entities and processes nationally, regionally and trans-regionally. The facility is aimed to promote a unified approach of EU standards and best practices in line with the EU Drugs Strategy and Action Plan and the EU Agenda on Security, in full compliance with international human rights standards, good governance principles and the rule of law, whilst ensuring that policy, research and best practices are inter-linked.

The flexible design of the targeted assistance shall facilitate dialogue with partner countries and open new channels of cooperation in the area of drugs with countries that had not received EU assistance in this area before and also strengthen multi-stakeholder engagement in this field. To the extent possible, focus is given to structural activities instead of one-off interventions.

It is expected that the assistance provided under the facility will be also feed into the process of trans-regional cooperation initiatives under Result/Component 3.

The requests to TAF can be made either from entities in non-key countries that fall within the project's geographical scope, or regional organisations or initiatives (ex. CARICC, ECO).

The mobilisation of appropriate expertise will require cooperation amongst project partners as well as reaching out to relevant EU Agencies and EUMS entities that can propose experts with a view to creating an experts’ roster.

These are some of the activities that might be considered for TAF support:

The EU-ACT Project can provide on-demand technical assistance, inter alia, in the following areas, prioritizing on policy/strategic aspects:

  • Provision of legal and technical advice in relation to the existing laws, and draft law and regulation´s initiatives taken to empower law enforcement and judicial authorities with the competences to effectively investigate drug trafficking and associated organized crime;
  • Provision of advice on draft laws, regulations and practices related to the above, in order to establish balances and counter-balances that guarantee a full respect of human rights throughout all the investigation and prosecution process;
  • Provision of technical advice to draw national strategies on drugs that balance both drug offer and demand reduction, and includes rehabilitation and harm reduction measures.
  • Analysis of existing policies, strategies, laws and regulations that address drug offer and demand reduction;
  • Provision of technical advice (it may be followed by a train-the-trainer activity) to design training curricula for investigators, prosecutors and judges on focused advanced investigative techniques, strategic/operational analysis and financial investigations;
  • Provision of support to Research and Development, such as promoting the capturing of data that can inform evidence-based policies; research into and analysis of data and statistics on drug use, in order to inform policies and strategies; including Research methodologies and techniques;
  • Provision of support to initiatives that facilitate the collaboration among governments, its institutions and civil society including non-governmental organizations and the private sector (for example, media) on drug demand reduction measures;
  • Production of and/or promotion of special focused manuals, catalogues of good practices and other pedagogical resources in order to support adopted policies and prevention campaigns; it may be complemented by a train-the-trainer activity (for example, on NPS treatment);
  • Technical advice on legislative and regulatory framework and practice in relation to incarceration -and other alternatives-, treatment and rehabilitation of prisoners;
  • Technical support to the development of national drug observatories / drug research centers;
  • Support to the assessing of the outcomes and impact of drug policies: the impact that drugs have on a range of other areas including economy, governance, public health, human rights, security;

In all the above related fields, the Project can provide support for the enhancement of dialogue, training and practical exchange of knowledge and experience between countries, both regionally and trans-regionally (feeding into C3 component, COPI).